Daily Market Reports | Feb 17 2026
This story features POINTERRA LIMITED, and other companies.
For more info SHARE ANALYSIS: 3DP
An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities.
In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.
One key difference is the *Extra* Edition will not be updated daily, but merely “regularly” depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.
Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena’s team of journalists.
Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.
The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.
The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.
COMPANIES DISCUSSED IN THIS ISSUE
Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)
3DP ACW AEL AMP ANZ AOV ARF ASX AWJ BC8 BRG BVS CBA CIP CLW CSL EOS GEM HDN IAG NST ORA ORG PLS PME TPW
3DP POINTERRA LIMITED
Cloud services – Overnight Price: $0.05
Research as a Service (RaaS) rates ((3DP)) as No Rating (-1) –
Research as a Service (RaaS) looks at Pointerra, a SaaS platform used for managing, visualising, analysing and sharing massive 3D point clouds and geo-spatial datasets, which allows it to predict answers to complicated physical asset management questions.
The 2Q26 cash flow of $0.472m was positive from a cash outflow in 1Q26 of -$0.13m. Over 1H26 cash flow improved from 2H25 but came in below a year previously.
Cash costs met the analyst’s forecast, although cash received of $4.59m was lower than anticipated. RaaS has not changed earnings forecasts with the full 1H26 results due at the end of February, but notes the 2Q update included a US$2m Department of Energy program that has started.
The analyst has a base case valuation of 25c per share and owns the stock.
This report was published on February 11, 2026.
Target price is $0.25 Current Price is $0.05 Difference: $0.2
If 3DP meets the Research as a Service (RaaS) target it will return approximately 400% (excluding dividends, fees and charges).
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
ACW ACTINOGEN MEDICAL LIMITED
Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $0.04
Canaccord Genuity rates ((ACW)) as Speculative Buy (1) –
Actinogen Medical’s Xanamem has cleared a bar that many others in the Alzheimer’s drug development area have failed at, Canaccord Genuity asserts, and with the drug passing futility analysis it means a continuation of the trial is warranted.
The broker also understands the company will meet the European Medicines Agency in April to discuss conditional marketing authorisation as an option should XanaMIA be successful.
Speculative Buy rating and 8c target.
This report was published on February 11, 2026.
Target price is $0.08 Current Price is $0.04 Difference: $0.04
If ACW meets the Canaccord Genuity target it will return approximately 100% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 1.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 4.00.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of 0.00 cents.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
AEL AMPLITUDE ENERGY LIMITED
Crude Oil – Overnight Price: $2.30
Canaccord Genuity rates ((AEL)) as Buy (1) –
Amplitude Energy’s Elanora-1 well intersected the primary Waarre A reservoir without elevated gas readings. This may be disappointing yet Canaccord Genuity suggests near-term production at the ECSP remains unaffected.
The other three targets of Isabella, Juliet and Nestor continue to be supported by seismic amplitudes and geological analogues to existing discoveries.
The broker remains confident in the remaining program but removes value for Elanora. Buy rating. Target is reduced to $3.35 from $3.68.
This report was published on February 11, 2026.
Target price is $3.35 Current Price is $2.30 Difference: $1.05
If AEL meets the Canaccord Genuity target it will return approximately 46% (excluding dividends, fees and charges).
Current consensus price target is $3.45, suggesting upside of 49.8%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 13.70 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 16.79.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 8.6, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 26.7.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of 17.50 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 13.14.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 12.4, implying annual growth of 44.2%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 18.5.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
AMP AMP LIMITED
Wealth Management & Investments – Overnight Price: $1.39
Jarden rates ((AMP)) as Upgrade to Overweight from Neutral (2) –
Although AMP’s 1H26 headline earnings were flat versus consensus and -2.8% below Jarden, AMP benefitted from a lower tax rate and a strong Corporate result, with core divisions significantly below expectations.
Within platforms, net inflows were offset by a softer revenue margin. For the Bank, Jarden has reservations about AMP’s strategy and it is difficult for the broker to see a credible pathway for AMP to compete given its weak deposit franchise and competition from scaled peers.
However, following a weak half, Jarden believes value is emerging at the price. Upgrade to Overweight from Neutral. Target falls to $1.65 from $1.85.
This report was published on February 16, 2026.
Target price is $1.65 Current Price is $1.39 Difference: $0.26
If AMP meets the Jarden target it will return approximately 19% (excluding dividends, fees and charges).
Current consensus price target is $1.84, suggesting upside of 32.4%(ex-dividends)
The company’s fiscal year ends in December.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 5.00 cents and EPS of 11.80 cents.
At the last closing share price the estimated dividend yield is 3.60%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 11.78.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 11.7, implying annual growth of 122.4%.
Current consensus DPS estimate is 4.0, implying a prospective dividend yield of 2.9%.
Current consensus EPS estimate suggests the PER is 11.9.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 6.00 cents and EPS of 11.90 cents.
At the last closing share price the estimated dividend yield is 4.32%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 11.68.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 12.6, implying annual growth of 7.7%.
Current consensus DPS estimate is 4.0, implying a prospective dividend yield of 2.9%.
Current consensus EPS estimate suggests the PER is 11.0.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
ANZ ANZ GROUP HOLDINGS LIMITED
Banks – Overnight Price: $39.63
Jarden rates ((ANZ)) as Overweight (2) –
ANZ Bank’s 1Q26 unaudited trading update showed reasonable business as usual trends, Jarden suggests.
ANZ has moved to the early stages of its Nuno Matos-led two tranche transformation which aims to lift returns with a step change in efficiency and execution excellence.
Targets under ANZ’s 2030 strategy remain on track and possibly ahead, with early signs of cost-out execution in effect. Nuno appears to be deploying a pragmatic plan in sound fashion, Jarden believes.
Overweight and $35 target retained.
This report was published on February 16, 2026.
Target price is $35.00 Current Price is $39.63 Difference: minus $4.63 (current price is over target).
If ANZ meets the Jarden target it will return approximately minus 12% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $36.79, suggesting downside of -7.2%(ex-dividends)
The company’s fiscal year ends in September.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 166.00 cents and EPS of 252.70 cents.
At the last closing share price the estimated dividend yield is 4.19%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 15.68.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 251.0, implying annual growth of 26.7%.
Current consensus DPS estimate is 168.0, implying a prospective dividend yield of 4.2%.
Current consensus EPS estimate suggests the PER is 15.8.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 166.00 cents and EPS of 271.60 cents.
At the last closing share price the estimated dividend yield is 4.19%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 14.59.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 257.8, implying annual growth of 2.7%.
Current consensus DPS estimate is 174.8, implying a prospective dividend yield of 4.4%.
Current consensus EPS estimate suggests the PER is 15.4.
Market Sentiment: -0.2
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
AOV AMOTIV LIMITED
Automobiles & Components – Overnight Price: $8.22
Canaccord Genuity rates ((AOV)) as Buy (1) –
Amotiv posted first half underlying EBITA that was ahead of Canaccord Genuity’s estimates.
Cash conversion improved significantly and the broker believes it was a solid result, given recent peer market announcements and anecdotes in the industry suggesting areas of difficult trading.
Management has reiterated FY26 guidance for around $195m in underlying EBITA. No changes are made to revenue assumptions while the broker’s EPS forecasts rise by 1.8% for FY26. Buy rating retained. Target rises to $12.10 from $11.20.
This report was published on February 10, 2026.
Target price is $12.10 Current Price is $8.22 Difference: $3.88
If AOV meets the Canaccord Genuity target it will return approximately 47% (excluding dividends, fees and charges).
Current consensus price target is $10.44, suggesting upside of 27.0%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 43.00 cents and EPS of 89.00 cents.
At the last closing share price the estimated dividend yield is 5.23%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 9.24.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 87.3, implying annual growth of N/A.
Current consensus DPS estimate is 41.5, implying a prospective dividend yield of 5.0%.
Current consensus EPS estimate suggests the PER is 9.4.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 45.00 cents and EPS of 97.00 cents.
At the last closing share price the estimated dividend yield is 5.47%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 8.47.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 95.0, implying annual growth of 8.8%.
Current consensus DPS estimate is 46.4, implying a prospective dividend yield of 5.6%.
Current consensus EPS estimate suggests the PER is 8.7.
Market Sentiment: 0.9
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
ARF ARENA REIT
REITs – Overnight Price: $3.55
Moelis rates ((ARF)) as Buy (1) –
Moelis considers the first half result “solid”, amid 3.6% like-for-like rental growth, while guidance was maintained.
Higher interest rates have signalled minor reductions to EPS forecasts and the broker considers the discount to NTA of -3% attractive despite tenant profitability challenges.
Gearing increased to 23.2% from 22.8% in the half providing capacity to support acquisitions and development. Buy rating. Target rises to $4.15 from $4.09.
This report was published on February 11, 2026.
Target price is $4.15 Current Price is $3.55 Difference: $0.6
If ARF meets the Moelis target it will return approximately 17% (excluding dividends, fees and charges).
Current consensus price target is $4.12, suggesting upside of 16.1%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 19.30 cents and EPS of 19.60 cents.
At the last closing share price the estimated dividend yield is 5.44%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 18.11.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 19.7, implying annual growth of -5.7%.
Current consensus DPS estimate is 19.2, implying a prospective dividend yield of 5.4%.
Current consensus EPS estimate suggests the PER is 18.0.
Forecast for FY27:
Moelis forecasts a full year FY27 dividend of 20.20 cents and EPS of 20.50 cents.
At the last closing share price the estimated dividend yield is 5.69%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 17.32.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 20.9, implying annual growth of 6.1%.
Current consensus DPS estimate is 20.3, implying a prospective dividend yield of 5.7%.
Current consensus EPS estimate suggests the PER is 17.0.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
ASX ASX LIMITED
Wealth Management & Investments – Overnight Price: $52.39
Jarden rates ((ASX)) as Neutral (3) –
While ASX’s 1H26 result was pre-announced and revenues continue to recover, the salient issue is how to balance costs, technology roll-out and shareholder returns, Jarden suggests.
Jarden expects the earnings (EBITDA) margin to trough in FY26 at 58.9% before lifting in outer years, but sees the EBIT margin trending lower as D&A rises to reflect ASX’s multi-year capex program.
Despite continuing to trade at a -21% PE discount to its ten-year average, given the execution and cost risk it faces, Jarden views this as appropriate. Target falls to $57.15 from $58.00 and Neutral retained.
This report was published on February 16, 2026.
Target price is $57.15 Current Price is $52.39 Difference: $4.76
If ASX meets the Jarden target it will return approximately 9% (excluding dividends, fees and charges).
Current consensus price target is $55.96, suggesting upside of 6.8%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 197.00 cents and EPS of 259.00 cents.
At the last closing share price the estimated dividend yield is 3.76%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 20.23.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 264.7, implying annual growth of 2.2%.
Current consensus DPS estimate is 198.6, implying a prospective dividend yield of 3.8%.
Current consensus EPS estimate suggests the PER is 19.8.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 207.00 cents and EPS of 269.00 cents.
At the last closing share price the estimated dividend yield is 3.95%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 19.48.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 269.0, implying annual growth of 1.6%.
Current consensus DPS estimate is 208.4, implying a prospective dividend yield of 4.0%.
Current consensus EPS estimate suggests the PER is 19.5.
Market Sentiment: -0.2
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
AWJ AURIC MINING LIMITED
Gold & Silver – Overnight Price: $0.30
Taylor Collison rates ((AWJ)) as Speculative Buy (1) –
Auric Mining has finished mining at the Munda starter pit with the final 65,000t of ore currently being processed at Lakewood.
Taylor Collison believes the December quarter has marked an inflection point with meaningful cash generation at a time of record gold prices.
Further cash inflow is expected in the March quarter, underpinned by firm gold prices.
Going forward, 2026 is about growth through exploration and development, and the broker considers the former the main short-term value driver once processing has finished. Speculative Buy rating. Target is lifted to $0.73.
This report was published on February 11, 2026.
Target price is $0.73 Current Price is $0.30 Difference: $0.43
If AWJ meets the Taylor Collison target it will return approximately 143% (excluding dividends, fees and charges).
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
BC8 BLACK CAT SYNDICATE LIMITED
Gold & Silver – Overnight Price: $1.40
Moelis rates ((BC8)) as Buy (1) –
Moelis highlights strong underground drill results from Black Cat Syndicate’s Paulsens project, confirming extensions to the historically mined Main Zone.
The broker highlights high-grade intercepts, including 5.1m at 14.3g/t gold and 8.7m at 7.7gold per tonne, supporting ongoing resource growth.
The analyst sees a “fill the mill” strategy emerging, with Belvedere due online in 2026 and an ore purchase agreement adding flexibility. A resource update is anticipated to replenish inventory.
Moelis expects a more streamlined company structure by FY27 as legacy arrangements conclude.
A Buy rating and target of $1.80 are retained.
This report was published on February 13, 2026.
Target price is $1.80 Current Price is $1.40 Difference: $0.4
If BC8 meets the Moelis target it will return approximately 29% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 0.00 cents and EPS of 20.10 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 6.97.
Forecast for FY27:
Moelis forecasts a full year FY27 dividend of 0.00 cents and EPS of 32.10 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 4.36.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
BRG BREVILLE GROUP LIMITED
Household & Personal Products – Overnight Price: $32.33
Jarden rates ((BRG)) as Overweight (2) –
Breville Group delivered solid top line growth in 1H26, Jarden suggests, with healthy gross margins in a tariff-impacted period, and guided to earnings a touch above consensus.
Longer term, Jarden likes Breville’s exposure to structural growth of the coffee machine category, opportunity to scale new markets like China, and scope to continue winning market share.
The broker sees the current multiple of 33x one-year forward PE as defendable (broadly similar to the average since FY19), though with limited scope to re-rate materially. Target rises to $34.90 from $31.00, Overweight retained.
This report was published on February 16, 2026.
Target price is $34.90 Current Price is $32.33 Difference: $2.57
If BRG meets the Jarden target it will return approximately 8% (excluding dividends, fees and charges).
Current consensus price target is $38.90, suggesting upside of 20.3%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 38.00 cents and EPS of 94.80 cents.
At the last closing share price the estimated dividend yield is 1.18%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 34.10.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 97.3, implying annual growth of 3.0%.
Current consensus DPS estimate is 38.3, implying a prospective dividend yield of 1.2%.
Current consensus EPS estimate suggests the PER is 33.2.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 44.00 cents and EPS of 106.60 cents.
At the last closing share price the estimated dividend yield is 1.36%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 30.33.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 110.7, implying annual growth of 13.8%.
Current consensus DPS estimate is 42.4, implying a prospective dividend yield of 1.3%.
Current consensus EPS estimate suggests the PER is 29.2.
Market Sentiment: 0.9
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
BVS BRAVURA SOLUTIONS LIMITED
Wealth Management & Investments – Overnight Price: $2.12
Canaccord Genuity rates ((BVS)) as Hold (3) –
Bravura Solutions posted a strong beat across all major revenue and earnings lines, Canaccord Genuity notes, supported by lower cash earnings.
The key for the shares to trade higher, Canaccord expects, will be the new CEO’s commentary on costs into 2H26, noting some further small headcount reductions seen over the half.
Hold and $2.00 target retained.
This report was published on February 16, 2026.
Target price is $2.00 Current Price is $2.12 Difference: minus $0.12 (current price is over target).
If BVS meets the Canaccord Genuity target it will return approximately minus 6% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
CBA COMMONWEALTH BANK OF AUSTRALIA
Banks – Overnight Price: $178.28
Jarden rates ((CBA)) as Sell (5) –
CommBank receives market rates on its assets and pays well below market rates on deposits, Jarden notes, which principally drives its margin advantage and valuation premium.
Jarden now finds this a precarious economic model vulnerable to disruption in a time when IT advancement has removed any proprietary distribution advantage that historically justified vast below market payment on deposits.
Macquariue Group ((MQG)) clearly sees this and is positioned to compete with a compelling offering that’s still in the early stages.
Jarden cuts its target by -10% to $90.00 to reflect the new margin challenge as CBA’s deposit moat has disappeared. Sell retained.
This report was published on February 16, 2026.
Target price is $90.00 Current Price is $178.28 Difference: minus $88.28 (current price is over target).
If CBA meets the Jarden target it will return approximately minus 50% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $129.71, suggesting downside of -27.2%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 505.00 cents and EPS of 634.00 cents.
At the last closing share price the estimated dividend yield is 2.83%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 28.12.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 656.6, implying annual growth of 8.5%.
Current consensus DPS estimate is 505.0, implying a prospective dividend yield of 2.8%.
Current consensus EPS estimate suggests the PER is 27.2.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 520.00 cents and EPS of 610.00 cents.
At the last closing share price the estimated dividend yield is 2.92%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 29.23.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 690.5, implying annual growth of 5.2%.
Current consensus DPS estimate is 531.0, implying a prospective dividend yield of 3.0%.
Current consensus EPS estimate suggests the PER is 25.8.
Market Sentiment: -1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
CIP CENTURIA INDUSTRIAL REIT
REITs – Overnight Price: $3.20
Moelis rates ((CIP)) as Buy (1) –
Centuria Industrial REIT delivered first half EPS and DPS of 9.1 cents and 8.4 cents respectively and tightened EPS guidance to 18.2-18.5 cents. Gearing increased to 35.9% from 33.2%.
As the company has committed to several acquisitions and developments, Moelis expects it will continue to target divestments as a funding source. Earnings estimates are lowered because of higher interest-rate assumptions, a little offset by lower debt margins.
The -10% decline in the share price over the past six months puts the stock on a -20% discount to NTA and the broker retains a Buy rating. Target edges up to $3.86 from $3.84.
This report was published on February 12, 2026.
Target price is $3.86 Current Price is $3.20 Difference: $0.66
If CIP meets the Moelis target it will return approximately 21% (excluding dividends, fees and charges).
Current consensus price target is $3.51, suggesting upside of 9.7%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 16.80 cents and EPS of 18.30 cents.
At the last closing share price the estimated dividend yield is 5.25%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 17.49.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 26.8, implying annual growth of 27.9%.
Current consensus DPS estimate is 16.8, implying a prospective dividend yield of 5.3%.
Current consensus EPS estimate suggests the PER is 11.9.
Forecast for FY27:
Moelis forecasts a full year FY27 dividend of 17.00 cents and EPS of 19.00 cents.
At the last closing share price the estimated dividend yield is 5.31%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 16.84.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 32.1, implying annual growth of 19.8%.
Current consensus DPS estimate is 17.5, implying a prospective dividend yield of 5.5%.
Current consensus EPS estimate suggests the PER is 10.0.
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
CLW CHARTER HALL LONG WALE REIT
REITs – Overnight Price: $3.80
Jarden rates ((CLW)) as Underweight (4) –
First half results from Charter Hall Long WALE REIT were in line with Jarden’s estimates. The main issue the broker points to is the elevated gearing which, combined with rising interest-rate expectations, is eroding earnings growth.
Commentary states the REIT may have exposure to CPI-related increases but this is not enough to offset the impact of higher bank bill swap rates and interest expense. Growth options are therefore limited although balance sheet gearing is within target.
Jarden believes deploying more capital to fund acquisitions or a buyback would only exacerbate the interest expense. Underweight retained. Target slips to $4.20 from $4.50.
This report was published on February 12, 2026.
Target price is $4.20 Current Price is $3.80 Difference: $0.4
If CLW meets the Jarden target it will return approximately 11% (excluding dividends, fees and charges).
Current consensus price target is $4.17, suggesting upside of 9.8%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 25.50 cents and EPS of 25.50 cents.
At the last closing share price the estimated dividend yield is 6.71%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 14.90.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 25.4, implying annual growth of 53.4%.
Current consensus DPS estimate is 25.7, implying a prospective dividend yield of 6.8%.
Current consensus EPS estimate suggests the PER is 15.0.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 25.50 cents and EPS of 25.50 cents.
At the last closing share price the estimated dividend yield is 6.71%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 14.90.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 25.9, implying annual growth of 2.0%.
Current consensus DPS estimate is 26.0, implying a prospective dividend yield of 6.8%.
Current consensus EPS estimate suggests the PER is 14.7.
Market Sentiment: 0.1
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
CSL CSL LIMITED
Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $152.17
Canaccord Genuity rates ((CSL)) as Buy (1) –
CSL’s FY26 guidance is in trouble, Canaccord Genuity suggests. The profit outlook is surprisingly maintained after missing 1H26 forecasts. Themes include consecutive misses in immunoglobulins and albumin.
Bright spots exist in the broader portfolio but remain nascent contributors unlikely to offset structural weaknesses in the short term, Canaccord notes.
Behring’s segment contribution was down -7% Seqirus and Vifor both did better than expected but remain tertiary considerations.
CSL maintained FY26 guidance, implying an unprecedented degree of 1H/2H phasing. Canaccord is reviewing its estimates. Buy and $225 target, for now.
This report was published on February 16, 2026.
Target price is $225.00 Current Price is $152.17 Difference: $72.83
If CSL meets the Canaccord Genuity target it will return approximately 48% (excluding dividends, fees and charges).
Current consensus price target is $205.76, suggesting upside of 35.2%(ex-dividends)
Forecast for FY26:
Current consensus EPS estimate is 892.3, implying annual growth of N/A.
Current consensus DPS estimate is 441.2, implying a prospective dividend yield of 2.9%.
Current consensus EPS estimate suggests the PER is 17.1.
Forecast for FY27:
Current consensus EPS estimate is 1051.3, implying annual growth of 17.8%.
Current consensus DPS estimate is 498.5, implying a prospective dividend yield of 3.3%.
Current consensus EPS estimate suggests the PER is 14.5.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.6
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
EOS ELECTRO OPTIC SYSTEMS HOLDINGS LIMITED
Hardware & Equipment – Overnight Price: $6.30
Canaccord Genuity rates ((EOS)) as Buy (1) –
Electro Optic Systems has issued a comprehensive rebuttal to a recent targeted short report, which Canaccord Genuity views as in-line with its expectations, with no change to forecasts, valuation and conviction.
The company provided more detail on key opportunities within its contract backlog of $459m, which remains sufficient to underwrite Canaccord’s FY26 revenue forecasts, with incremental contract wins over FY26 potentially providing upside to revenue/earnings estimates.
Buy and $12 target retained.
This report was published on February 16, 2026.
Target price is $12.00 Current Price is $6.30 Difference: $5.7
If EOS meets the Canaccord Genuity target it will return approximately 90% (excluding dividends, fees and charges).
The company’s fiscal year ends in December.
Forecast for FY25:
Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 22.50 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 28.00.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 11.50 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 54.78.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
GEM G8 EDUCATION LIMITED
Childcare – Overnight Price: $0.48
Canaccord Genuity rates ((GEM)) as Hold (3) –
Ahead of its result, G8 Education has announced a -$350m impairment to goodwill, based on current and expected occupancy, compliance costs, current and expected supply and demand levels, and wage/operating costs.
While it’s not a great indication of how things are going for the company, Canaccord Genuity had assumed a soft start to the year from both an occupancy and news flow perspective. The update is thus not particularly surprising.
While the broker still sees some risk around the next occupancy update and other potential headlines, Canaccord believes we are close to the bottom, most of the risk has been cleansed, and it’s very rare for the stock to trade on multiples this low.
Hold and 80c target retained.
This report was published on February 16, 2026.
Target price is $0.80 Current Price is $0.48 Difference: $0.32
If GEM meets the Canaccord Genuity target it will return approximately 67% (excluding dividends, fees and charges).
The company’s fiscal year ends in December.
Forecast for FY25:
Canaccord Genuity forecasts a full year FY25 dividend of 4.50 cents and EPS of 8.00 cents.
At the last closing share price the estimated dividend yield is 9.38%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 6.00.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 5.00 cents and EPS of 9.00 cents.
At the last closing share price the estimated dividend yield is 10.42%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 5.33.
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
HDN HOMECO DAILY NEEDS REIT
REITs – Overnight Price: $1.32
Moelis rates ((HDN)) as Upgrade to Buy from Hold (1) –
Commenting after interim results, Moelis says HomeCo Daily Needs REIT continues to deliver strong operating metrics, with 6.2% leasing spreads and 4.0% like-for-like net operating income (NOI) growth.
The broker trims its medium-term EPS forecast on higher floating rates, partly offset by lower lending margins.
Moelis notes 1H26 FFO of 4.4cpu and a dividend of 4.3cpu, with occupancy above 99%. Gearing of 35.2% implies to the broker ongoing asset recycling to fund the $650m development pipeline.
The analyst sees the stock trading attractively at a -17% NTA discount and 6.2% implied cap rate.
The broker’s target rises to $1.46 from $1.44 and the rating is upgraded to Buy from Hold.
This report was published on February 12, 2026.
Target price is $1.46 Current Price is $1.32 Difference: $0.14
If HDN meets the Moelis target it will return approximately 11% (excluding dividends, fees and charges).
Current consensus price target is $1.40, suggesting upside of 5.8%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 8.60 cents and EPS of 9.00 cents.
At the last closing share price the estimated dividend yield is 6.52%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 14.67.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 9.0, implying annual growth of -25.1%.
Current consensus DPS estimate is 8.7, implying a prospective dividend yield of 6.6%.
Current consensus EPS estimate suggests the PER is 14.7.
Forecast for FY27:
Moelis forecasts a full year FY27 dividend of 8.80 cents and EPS of 9.20 cents.
At the last closing share price the estimated dividend yield is 6.67%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 14.35.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 9.2, implying annual growth of 2.2%.
Current consensus DPS estimate is 8.9, implying a prospective dividend yield of 6.7%.
Current consensus EPS estimate suggests the PER is 14.3.
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
IAG INSURANCE AUSTRALIA GROUP LIMITED
Insurance – Overnight Price: $6.93
Jarden rates ((IAG)) as Overweight (2) –
The first half result from Insurance Australia Group was underwhelming despite net profit exceeding expectations, which Jarden attributes to weak underlying trends. Specifically, gross written premium of 6% was well below guidance of 10%.
Home insurance grew in the mid-high single digits while motor was subdued with low single-digit growth. The outlook is still supported, the broker contends, by retail ex-RACQ and NZ margin expansion.
While continuing to expect AI will weigh on insurance stocks in the near term, Jarden assesses the risks to earnings appear minimal. Overweight. Target reduced to $8.10 from $8.20.
This report was published on February 13, 2026.
Target price is $8.10 Current Price is $6.93 Difference: $1.17
If IAG meets the Jarden target it will return approximately 17% (excluding dividends, fees and charges).
Current consensus price target is $8.45, suggesting upside of 21.9%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 30.00 cents and EPS of 42.60 cents.
At the last closing share price the estimated dividend yield is 4.33%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 16.27.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 44.2, implying annual growth of -23.1%.
Current consensus DPS estimate is 30.5, implying a prospective dividend yield of 4.4%.
Current consensus EPS estimate suggests the PER is 15.7.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 33.00 cents and EPS of 45.80 cents.
At the last closing share price the estimated dividend yield is 4.76%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 15.13.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 48.1, implying annual growth of 8.8%.
Current consensus DPS estimate is 33.3, implying a prospective dividend yield of 4.8%.
Current consensus EPS estimate suggests the PER is 14.4.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
NST NORTHERN STAR RESOURCES LIMITED
Gold & Silver – Overnight Price: $28.46
Jarden rates ((NST)) as Underweight (4) –
Northern Star Resources delivered a first half result that slightly beat Jarden’s estimates. The fully franked $0.25 dividend was in line. No further capital management initiatives were flagged.
The broker points out the company’s assets have underperformed the underlying commodity price despite the company emphasising its “healthy EBITDA margins”.
Jarden acknowledges the company continues to capitalise a vast amount of expenditure rather than running it through EBITDA. Underweight. Target is reduced to $17.00 from $17.20.
This report was published on February 12, 2026.
Target price is $17.00 Current Price is $28.46 Difference: minus $11.46 (current price is over target).
If NST meets the Jarden target it will return approximately minus 40% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $31.05, suggesting upside of 9.1%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 50.00 cents and EPS of 148.40 cents.
At the last closing share price the estimated dividend yield is 1.76%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 19.18.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 154.7, implying annual growth of 37.3%.
Current consensus DPS estimate is 56.3, implying a prospective dividend yield of 2.0%.
Current consensus EPS estimate suggests the PER is 18.4.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 50.00 cents and EPS of 173.70 cents.
At the last closing share price the estimated dividend yield is 1.76%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 16.38.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 231.9, implying annual growth of 49.9%.
Current consensus DPS estimate is 76.9, implying a prospective dividend yield of 2.7%.
Current consensus EPS estimate suggests the PER is 12.3.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
ORA ORORA LIMITED
Paper & Packaging – Overnight Price: $2.19
Jarden rates ((ORA)) as Buy (1) –
Orora delivered a first half result that was better than Jarden feared. Volume growth has returned with an improved performance in Saverglass amid a tough industry backdrop.
Sustained volume strength and price/mix realisation was also observed in cans.
The broker suspects the market needs more evidence the volume and earnings performance has improved for Saverglass, but suspects this might miss the signal that a trough has occurred in the first half.
Buy rating and $2.60 target maintained. The next catalyst is expected to be a trading update in May.
This report was published on February 12, 2026.
Target price is $2.60 Current Price is $2.19 Difference: $0.41
If ORA meets the Jarden target it will return approximately 19% (excluding dividends, fees and charges).
Current consensus price target is $2.29, suggesting upside of 4.6%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 10.10 cents and EPS of 13.40 cents.
At the last closing share price the estimated dividend yield is 4.61%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 16.34.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 13.2, implying annual growth of 22.7%.
Current consensus DPS estimate is 10.3, implying a prospective dividend yield of 4.7%.
Current consensus EPS estimate suggests the PER is 16.6.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 12.50 cents and EPS of 16.70 cents.
At the last closing share price the estimated dividend yield is 5.71%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 13.11.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 14.9, implying annual growth of 12.9%.
Current consensus DPS estimate is 11.0, implying a prospective dividend yield of 5.0%.
Current consensus EPS estimate suggests the PER is 14.7.
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
ORG ORIGIN ENERGY LIMITED
Infrastructure & Utilities – Overnight Price: $11.84
Jarden rates ((ORG)) as Upgrade to Overweight from Neutral (2) –
Origin Energy has upgraded FY26 energy markets EBITDA guidance by 6.5%. Jarden notes the highlight of the interim result was strong electricity gross profit which beat estimates.
The broker suspects the market was concerned the low volatility during the half could translate into lower earnings but a combination of higher customer tariffs, lower net pool costs, lower green scheme costs and lower solar FiT drove a beat to expectations.
Jarden increases FY26 energy markets EBITDA estimates by 5.8%.
The company has acknowledged lower wholesale electricity prices will negatively affect electricity earnings in FY27, but the broker expects this will be more than offset by lower coal costs and increased battery earnings.
Rating is upgraded to Overweight from Neutral. Target rises to $12.00 from $11.65.
This report was published on February 13, 2026.
Target price is $12.00 Current Price is $11.84 Difference: $0.16
If ORG meets the Jarden target it will return approximately 1% (excluding dividends, fees and charges).
Current consensus price target is $12.03, suggesting upside of 1.6%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 60.00 cents and EPS of 86.90 cents.
At the last closing share price the estimated dividend yield is 5.07%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 13.62.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 69.3, implying annual growth of -19.6%.
Current consensus DPS estimate is 60.0, implying a prospective dividend yield of 5.1%.
Current consensus EPS estimate suggests the PER is 17.1.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 60.00 cents and EPS of 59.20 cents.
At the last closing share price the estimated dividend yield is 5.07%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 20.00.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 60.4, implying annual growth of -12.8%.
Current consensus DPS estimate is 63.1, implying a prospective dividend yield of 5.3%.
Current consensus EPS estimate suggests the PER is 19.6.
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
PLS PLS GROUP LIMITED
New Battery Elements – Overnight Price: $4.31
Canaccord Genuity rates ((PLS)) as Buy (1) –
PLS Group has announced a new two-year binding offtake agreement with Chinese battery manufacturer Canmax Technologies for the supply of spodumene concentrate.
PLS has noted it is capable of fulfilling the offtake with Pilgan Plant concentrate given spare capacity following reduced concentrate consumption at its POSCO JV.
Canaccord Genuity also notes the company has been preparing its Ngungaju Plant for a restart.
Buy retained, target $5.30.
This report was published on February 16, 2026.
Target price is $5.30 Current Price is $4.31 Difference: $0.99
If PLS meets the Canaccord Genuity target it will return approximately 23% (excluding dividends, fees and charges).
Current consensus price target is $4.85, suggesting upside of 12.5%(ex-dividends)
Forecast for FY26:
Current consensus EPS estimate is 13.2, implying annual growth of N/A.
Current consensus DPS estimate is 0.8, implying a prospective dividend yield of 0.2%.
Current consensus EPS estimate suggests the PER is 32.7.
Forecast for FY27:
Current consensus EPS estimate is 28.4, implying annual growth of 115.2%.
Current consensus DPS estimate is 4.6, implying a prospective dividend yield of 1.1%.
Current consensus EPS estimate suggests the PER is 15.2.
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
PME PRO MEDICUS LIMITED
Medical Equipment & Devices – Overnight Price: $116.97
Moelis rates ((PME)) as Hold (3) –
Pro Medicus’ 1H26 result missed expectations held by Moelis, though fundamentals remain intact, according to the broker.
Revenue of $124.8m rose by 28%, with NPAT rising 29%, but both were below consensus on contract timing, explain the analysts. It’s noted the earnings (EBIT) margin improved to 73%, up from 72% in H1 FY25.
The broker trims its FY26-28 EPS forecasts by between -2-8% on ramp-up timing and FX, partly offset by repricing. It believes AI risk is limited given regulation, proprietary technology and strong implementation capability.
The analysts expect around 30% annual growth in revenue, supported by a solid pipeline and low US market share.
Moelis retains a Hold rating. The target is lowered to $141.04 from $325.82.
This report was published on February 13, 2026.
Target price is $141.04 Current Price is $116.97 Difference: $24.07
If PME meets the Moelis target it will return approximately 21% (excluding dividends, fees and charges).
Current consensus price target is $273.17, suggesting upside of 133.5%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 67.00 cents and EPS of 139.80 cents.
At the last closing share price the estimated dividend yield is 0.57%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 83.67.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 185.4, implying annual growth of 68.1%.
Current consensus DPS estimate is 67.8, implying a prospective dividend yield of 0.6%.
Current consensus EPS estimate suggests the PER is 63.1.
Forecast for FY27:
Moelis forecasts a full year FY27 dividend of 96.00 cents and EPS of 189.50 cents.
At the last closing share price the estimated dividend yield is 0.82%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 61.73.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 187.1, implying annual growth of 0.9%.
Current consensus DPS estimate is 89.8, implying a prospective dividend yield of 0.8%.
Current consensus EPS estimate suggests the PER is 62.5.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
TPW TEMPLE & WEBSTER GROUP LIMITED
Furniture & Renovation – Overnight Price: $7.64
Petra Capital rates ((TPW)) as Buy (1) –
Petra Capital assesses Temple & Webster’s weak point in the first half results was the cost to the margin from the focus on growing market share to take advantage of the shift to online, but considers this a cyclical factor rather than a structural issue for the business.
Some of the positives that have been overlooked in the result include leverage on fixed costs and marketing, intact customer metrics and strongly performing growth areas. Supplier support is also intact.
The broker reduces FY26-28 estimates for EPS by -15-19% and lowers the target to $13.00 from $20.15. Buy rating maintained.
This report was published on February 13, 2026.
Target price is $13.00 Current Price is $7.64 Difference: $5.36
If TPW meets the Petra Capital target it will return approximately 70% (excluding dividends, fees and charges).
Current consensus price target is $15.88, suggesting upside of 107.8%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Petra Capital forecasts a full year FY26 dividend of 0.00 cents and EPS of 10.10 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 75.64.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 9.9, implying annual growth of 4.0%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 77.2.
Forecast for FY27:
Petra Capital forecasts a full year FY27 dividend of 0.00 cents and EPS of 16.10 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 47.45.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 18.2, implying annual growth of 83.8%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 42.0.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don’t have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide experienced, intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface.
This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.
<span style="
Click to view our Glossary of Financial Terms
CHARTS
For more info SHARE ANALYSIS: 3DP - POINTERRA LIMITED
For more info SHARE ANALYSIS: ACW - ACTINOGEN MEDICAL LIMITED
For more info SHARE ANALYSIS: AEL - AMPLITUDE ENERGY LIMITED
For more info SHARE ANALYSIS: AMP - AMP LIMITED
For more info SHARE ANALYSIS: ANZ - ANZ GROUP HOLDINGS LIMITED
For more info SHARE ANALYSIS: AOV - AMOTIV LIMITED
For more info SHARE ANALYSIS: ARF - ARENA REIT
For more info SHARE ANALYSIS: ASX - ASX LIMITED
For more info SHARE ANALYSIS: AWJ - AURIC MINING LIMITED
For more info SHARE ANALYSIS: BC8 - BLACK CAT SYNDICATE LIMITED
For more info SHARE ANALYSIS: BRG - BREVILLE GROUP LIMITED
For more info SHARE ANALYSIS: BVS - BRAVURA SOLUTIONS LIMITED
For more info SHARE ANALYSIS: CBA - COMMONWEALTH BANK OF AUSTRALIA
For more info SHARE ANALYSIS: CIP - CENTURIA INDUSTRIAL REIT
For more info SHARE ANALYSIS: CLW - CHARTER HALL LONG WALE REIT
For more info SHARE ANALYSIS: CSL - CSL LIMITED
For more info SHARE ANALYSIS: EOS - ELECTRO OPTIC SYSTEMS HOLDINGS LIMITED
For more info SHARE ANALYSIS: GEM - G8 EDUCATION LIMITED
For more info SHARE ANALYSIS: HDN - HOMECO DAILY NEEDS REIT
For more info SHARE ANALYSIS: IAG - INSURANCE AUSTRALIA GROUP LIMITED
For more info SHARE ANALYSIS: MQG - MACQUARIE GROUP LIMITED
For more info SHARE ANALYSIS: NST - NORTHERN STAR RESOURCES LIMITED
For more info SHARE ANALYSIS: ORA - ORORA LIMITED
For more info SHARE ANALYSIS: ORG - ORIGIN ENERGY LIMITED
For more info SHARE ANALYSIS: PLS - PLS GROUP LIMITED
For more info SHARE ANALYSIS: PME - PRO MEDICUS LIMITED
For more info SHARE ANALYSIS: TPW - TEMPLE & WEBSTER GROUP LIMITED